By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Finance > Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more
Finance

Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more

Last updated: August 5, 2025 2:29 am
2 days ago
Share
SHARE


Check out the companies making headlines in extended trading. Palantir — The defense technology stock advanced 4% after second-quarter earnings exceeded Wall Street’s expectations. Palantir said it reported adjusted earnings of 16 cents per share on $1.00 billion in revenue, while analysts polled by LSEG anticipated 14 cents per share and $940 million, respectively. Vertex Pharmaceuticals — The biotech stock sank 14% after second-quarter earnings topped estimates. Vertex posted adjusted earnings of $4.52 per share on revenue of $2.96 billion, while analysts surveyed by LSEG had penciled in $4.26 per share and $2.91 billion. Hims & Hers Health – Shares tumbled 12% after the telehealth company issued disappointing guidance. Hims sees third-quarter adjusted earnings before interest, taxes, depreciation and amortization ranging from $60 million to $70 million, while StreetAccount consensus estimates called for $77 million. Second-quarter results were mixed, with revenue missing expectations, while adjusted earnings narrowly beat. Syndax Pharmaceuticals – The biopharma stock slipped 3% after Syndax guided for a third-quarter research and development expense of between $95 million to $100 million, while analysts polled by FactSet had expected $65.8 million. However, the company posted second-quarter revenue that exceeded expectations, as well as a narrower-than-expected loss per share. Dorman Products — The vehicle part supplier popped 7% after hiking its full-year earnings guidance to between $8.60 and $8.90 per share, excluding items, from a range of $7.55 to $7.85 a share. Dorman also issued better-than-expected top- and bottom-line results for the second quarter, per FactSet. V2X – Shares rose more than 2% after the aerospace and defense company’s second-quarter results beat Wall Street’s expectations. V2X posted adjusted earnings of 33 cents per share, while analysts polled by FactSet had penciled in 97 cents per share. The company’s revenue of $1.08 billion also beat the consensus estimate of $1.05 billion. Additionally, it raised its full-year earnings forecast. MercadoLibre — Shares dropped 4% after the Latin American e-commerce platform reported second-quarter earnings that missed expectations. MercadoLibre posted earnings of $10.31 per share, below the $11.93 per share estimated by analysts polled by FactSet. On the other hand, expected revenue of $6.79 billion topped the $6.67 billion consensus estimate. — CNBC’s Darla Mercado, Sean Conlon, Lisa Kailai Han and Sarah Min contributed reporting



Source link

You Might Also Like

Radhika Gupta recommends ‘favourite’ Nifty 500 index for smart investment, says delivers three benefits. Take a look | Stock Market News

Trump’s tariff playbook comes with a baseball twist

War-weary Syria will be hurt further by Trump’s 41% tariff rate — the highest on earth

Gold prices today in your city: Check prices in Mumbai, Bengaluru, Chennai, Hyderabad, Delhi, Kolkata on August 6 | Stock Market News

Opendoor tanks after earnings as CEO thanks new investors for ‘increased visibility’

TAGGED:Breaking News: MarketsBusinessBusiness NewsDorman Products IncEconomyHims & Hers Health IncMarket InsiderMarketsMercadoLibre IncPalantir Technologies Incregwall-marketmoversStock marketsSyndax Pharmaceuticals IncV2X IncVertex Pharmaceuticals Inc
Share This Article
Facebook Twitter Email Print
Previous Article Contentious July jobs report confirms the U.S. economy is slowing sharply. Here’s why
Next Article Top 3 stocks to buy today—recommended by Ankush Bajaj for 5 August
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS